Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma
- 25 December 2004
- journal article
- clinical trial
- Published by Elsevier BV in Cancer Letters
- Vol. 224 (1), 67-80
- https://doi.org/10.1016/j.canlet.2004.10.050
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Arginine catabolism, liver extracts and cancerPathology and Oncology Research, 2002
- PegylationClinical Pharmacokinetics, 2001
- Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cellsBritish Journal of Cancer, 2000
- Arginine metabolism: nitric oxide and beyondBiochemical Journal, 1998
- Arginine: Biochemistry, Physiology, and Therapeutic ImplicationsJournal of Parenteral and Enteral Nutrition, 1986
- The Effects of Arginine Deficiency on Lymphoma CellsBritish Journal of Cancer, 1974
- The Effect of Arginase on the Retardation of Tumour GrowthBritish Journal of Cancer, 1965
- Enzymes of Arginine Metabolism in Mammalian Cell CulturePublished by Elsevier BV ,1964
- Inhibition of growth of cultured mammalian cells by liver extractsBiochimica et Biophysica Acta, 1960